Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KOSDAQ/086450 stock hub

KOSDAQ/086450 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/086450is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/086450
In the news

Latest news · KOSDAQ/086450

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.3
P25 9.8P50 17.1P75 31.9
Trailing P/E15.7
P25 12P50 23.1P75 39.5
ROE10.2
P25 -17.1P50 0.7P75 8.5
ROIC10.9
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/086450 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
244
Groups with data
11
Currency
KRW
Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
1,233
Enterprise value
KRW 1.1T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7086450004
Last refreshed
2026-05-10
Market cap
KRW 1T
Price
KRW 23,100
Price currency
KRW
Rev Per Employee
751,730,496.2x
Sector
Healthcare
Sic
2834
Symbol
kosdaq/086450
Website
https://www.dkpharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
6.34%
EV Earnings
16.53x
EV/EBIT
11.76x
EV/EBITDA
8.76x
EV/FCF
41.9x
EV/Sales
1.18x
FCF yield
2.5%
Forward P/E
12.26x
P/B ratio
1.36x
P/E ratio
15.66x
P/S ratio
1.12x
PE Ratio10 Y
14.8x
PE Ratio3 Y
13.22x
PE Ratio5 Y
15.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
10.41%
EBITDA Margin
13.83%
FCF margin
2.81%
Gross margin
54.08%
Gross Profit
KRW 501.2B
Gross Profit Growth
11.99%
Gross Profit Growth Q
16.81%
Gross Profit Growth3 Y
9.7%
Gross Profit Growth5 Y
8.26%
Net Income
KRW 66B
Net Income Growth
7.84%
Net Income Growth Q
60.49%
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Net Income Growth3 Y
7.67%
Net Income Growth5 Y
3.37%
Pretax Margin
9.99%
Profit Margin
7.12%
Profit Per Employee
KRW 53.5M
Profitable Years
14
ROA
5.98
Roa5y
5.68
ROCE
12.13
ROE
10.25
Roe5y
9.95
ROIC
10.9
Roic5y
10.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

28
MetricValue
Cagr10y
7.2%
Cagr15y
15.11%
Cagr1y
51.62%
Cagr3y
15.51%
Cagr5y
-2.86%
Div CAGR10
9.6%
Div CAGR3
3.57%
Div CAGR5
2.13%
EPS Growth
7.79
EPS Growth Q
60.19
EPS Growth Quarters
3
EPS Growth Years
2
EPS Growth3 Y
7.63
EPS Growth5 Y
3.35
FCF Growth
-46.63%
FCF Growth Q
-61.36%
FCF Growth5 Y
5.96%
OCF Growth
-9.63%
OCF Growth Q
-22.99%
OCF Growth10 Y
9.74%
OCF Growth3 Y
18.9%
OCF Growth5 Y
3.07%
Revenue Growth
14.13x
Revenue Growth Q
15.15x
Revenue Growth Quarters
17x
Revenue Growth Years
13x
Revenue Growth3 Y
11.89x
Revenue Growth5 Y
10.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.92
Assets
KRW 1.1T
Cash
KRW 127.1B
Current Assets
KRW 565.4B
Current Liabilities
KRW 267.4B
Debt
KRW 76.2B
Debt EBITDA
KRW 0.59
Debt Equity
KRW 0.1
Debt FCF
KRW 2.93
Equity
KRW 763.7B
Interest Coverage
46.44
Liabilities
KRW 299.2B
Long Term Assets
KRW 497.5B
Long Term Liabilities
KRW 31.7B
Net Cash
KRW 50.9B
Net Cash By Market Cap
KRW 4.88
Net Cash Growth
400.27%
Net Debt EBITDA
KRW -0.4
Net Debt Equity
KRW -0.07
Net Debt FCF
KRW -1.95
Tangible Book Value
KRW 631.3B
Tangible Book Value Per Share
KRW 13,995
WACC
4.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.11
Inventory Turnover
2.54
Net Working Capital
KRW 226.3B
Quick ratio
1.39
Working Capital
KRW 298B
Working Capital Turnover
KRW 3.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.05%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
KRW 200
Dividend Years
19
Dividend Yield
0.87%
Ex Div Date
2025-12-29
Last Dividend
KRW 200
Payout Frequency
Annual
Payout Ratio
14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
100.37%
1Y total return
51.58%
200-day SMA
19,321.6
3Y total return
54.13%
50-day SMA
22,832.8
50-day SMA vs 200-day SMA
50over200
5Y total return
-13.52%
All Time High
36,150
All Time High Change
-36.1%
All Time High Date
2020-09-10
All Time Low
1,496.9
All Time Low Change
1,443.17%
All Time Low Date
2008-10-28
ATR
1,302.1
Beta
0.09
Beta1y
0.35
Beta2y
0.31
Ch YTD
34.69
High
23,700
High52
31,250
High52 Date
2026-04-06
High52ch
-26.08%
Low
22,950
Low52
15,170
Low52 Date
2025-05-08
Low52ch
53.69%
Ma50ch
1.17%
Price vs 200-day SMA
19.56%
RSI
43.3
RSI Monthly
63.24
RSI Weekly
57.72
Sharpe ratio
0.97x
Sortino ratio
1.96
Total Return
0.82%
Tr YTD
34.69
Tr15y
725.35%
Tr1m
-19.79%
Tr1w
-2.74%
Tr3m
32.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 96.5B
Operating Income Growth
20.8
Operating Income Growth Q
39.51
Operating Income Growth3 Y
9.47
Operating Income Growth5 Y
3.15
Operating margin
10.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
24,747,971%
Net Borrowing
-7,575,924,070
Shares Insiders
24.4%
Shares Institutions
19.59%
Shares Out
45,110,727
Shares Qo Q
0.17%
Shares Yo Y
0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

66
MetricValue
Adjusted FCF
KRW 26.2B
Average Volume
637,618.6x
Bv Per Share
14,713.6
CAPEX
KRW -42.7B
Ch10y
84.8
Ch15y
613
Ch1m
-19.79
Ch1w
-2.74
Ch1y
51.58
Ch3m
32.38
Ch3y
50.59
Ch5y
-17.06
Ch6m
32.68
Change
-0.86%
Change From Open
-2.53
Close
23,300
Days Gap
1.72
Depreciation Amortization
31,711,703,000
Dollar Volume
4,154,789,100
Earnings Date
2026-05-15
EBIT
KRW 96.5B
EBITDA
KRW 128.2B
EPS
KRW 1,475
F Score
7
FCF
KRW 26B
FCF EV Yield
2.39x
FCF Per Share
KRW 577
Financing CF
-996,966,010
Fiscal Year End
December
Founded
1,968
Goodwill
12,171,644,000
Graham Number
22097.68629
Graham Upside
-4.34
Income Tax
KRW 18.7B
Investing CF
-61,624,466,760
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2020-08-24
Last Split Type
Forward
Lynch Fair Value
KRW 7,375
Lynch Upside
-68.07
Ma150
19,734.3
Ma150ch
17.05%
Ma20
25,162.5
Ma20ch
-8.2%
Net CF
5,907,128,810
Next Earnings Date
2026-05-15
Open
23,700
P FCF Ratio
40.01
P OCF Ratio
15.15
Payment Date
2026-04-17
Position In Range
20
Ppne
312,222,209,150
Price Date
2026-05-08
Price EBITDA
KRW 8.13
Ptbv Ratio
1.65
Relative Volume
0.26x
Revenue
926,883,701,820x
SBC By Revenue
-0.01x
Share Based Comp
-115,895,000
Tax By Revenue
2.01x
Tax Rate
20.15%
Tr6m
32.68%
Volume
179,861
Z Score
3.83
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/086450 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.9%
$200 annual per share
Payout ratio
+14.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+2.1%
0 consecutive years of growth
Total shareholder yield
+0.8%
Next ex-dividend date: 2025-12-29
Performance

KOSDAQ/086450 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+51.6%
S&P 500 1Y: n/a
3Y total return
+54.1%
S&P 500 3Y: n/a
5Y total return
-13.5%
S&P 500 5Y: n/a
10Y total return
+100.4%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/086450?

Insider, institutional, and short-interest positioning.

Institutional ownership
+19.6%
Share of float held by funds and institutions
Insider ownership
+24.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

KOSDAQ/086450 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.3
Neutral momentum band
Price vs 200-day MA
+19.6%
50/200-day relationship not available
Beta (5Y)
0.09
Less volatile than the market
Sharpe ratio
0.97
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/086450

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/086450 stock rating?

kosdaq/086450 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/086450 analysis?

The full report lives at /stocks/kosdaq/086450/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/086450?

The latest report frames kosdaq/086450 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/086450 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.